E. Kerwin, L. Murray, V. Ganapathy, C. Dembek, K. Rajagopalan
{"title":"两项随机、双盲、安慰剂对照研究的合并数据显示,甘炔罗酸流®封闭系统(CS)(雾化甘炔罗酸)治疗慢性阻塞性肺疾病(COPD)患者的临床重要恶化","authors":"E. Kerwin, L. Murray, V. Ganapathy, C. Dembek, K. Rajagopalan","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4524","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":170264,"journal":{"name":"C32. COPD: TRANSLATIONAL AND MECHANISTIC STUDIES","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Glycopyrrolate Eflow® Closed System (CS) (nebulized Glycopyrrolate) in Pooled Data from Two Randomized, Double Blind, Placebo-Controlled Studies\",\"authors\":\"E. Kerwin, L. Murray, V. Ganapathy, C. Dembek, K. Rajagopalan\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4524\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":170264,\"journal\":{\"name\":\"C32. COPD: TRANSLATIONAL AND MECHANISTIC STUDIES\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C32. COPD: TRANSLATIONAL AND MECHANISTIC STUDIES\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4524\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C32. COPD: TRANSLATIONAL AND MECHANISTIC STUDIES","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4524","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Glycopyrrolate Eflow® Closed System (CS) (nebulized Glycopyrrolate) in Pooled Data from Two Randomized, Double Blind, Placebo-Controlled Studies